Friday, April 19, 2013

What are the best practices for Clinical Trial design, agency interactions and regulatory document writing?

Successful Drug Development:
Best Practices for Clinical Trial Design,Agency Interactions and Regulatory Document Writing
June 23 from 1:00PM – 4:30PM in Boston

This tutorial will cover common mistakes and solutions in the areas of drug development planning, clinical study design, statistical analysis planning, regulatory agency interactions and regulatory document writing. Practical advice for each of these areas will be presented, with an emphasis on learning from past examples that illustrate approaches to adopt or to avoid.

Elaine B. Taylor ,
Associate Director, Regulatory Strategy, Consulting, and Submissions
INC Research, United States

Kathy Wekselman,
Director, Regulatory and Scientific Affairs
CTI Clinical Trial and Consulting Services, United States

What’s more…Receive $100 off of your DIA 2013 Annual Meeting registration by registering for two half day tutorials or one full day tutorial. Please note purchases must be made at the same time in order to receive the discount.

Visit for more details on the DIA 2013 Annual Meeting being held June 23-27 in Boston, MA.

Sign up for DIA's Global SmartBrief eNews for the latest in drug development innovations worldwide.

No comments:

Post a Comment